Paolo Gisondi

17.2k total citations · 3 hit papers
285 papers, 8.7k citations indexed

About

Paolo Gisondi is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Paolo Gisondi has authored 285 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Immunology, 120 papers in Dermatology and 82 papers in Rheumatology. Recurrent topics in Paolo Gisondi's work include Psoriasis: Treatment and Pathogenesis (178 papers), Dermatology and Skin Diseases (84 papers) and Spondyloarthritis Studies and Treatments (53 papers). Paolo Gisondi is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (178 papers), Dermatology and Skin Diseases (84 papers) and Spondyloarthritis Studies and Treatments (53 papers). Paolo Gisondi collaborates with scholars based in Italy, United States and United Kingdom. Paolo Gisondi's co-authors include Giampiero Girolomoni, Micol Del Giglio, Giovanni Targher, Francesco Bellinato, Stefano Piaserico, Andrea Conti, Cristina Albanesi, G Tessari, Martina Maurelli and Giacomo Zoppini and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Clinical Nutrition and International Journal of Molecular Sciences.

In The Last Decade

Paolo Gisondi

257 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study

2007 534 citations Paolo Gisondi, Andrea Conti et al. British Journal of Dermatology profile →
Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies

2018 444 citations Laura C. Coates, Paolo Gisondi et al. profile →
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis

2018 320 citations Paolo Gisondi, Giampiero Girolomoni et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paolo Gisondi Italy	49	5.8k	3.3k	2.5k	985	981	285	8.7k
Jashin J. Wu United States	42	4.9k 0.8×	2.9k 0.9×	1.6k 0.7×	877 0.9×	731 0.7×	375	7.6k
Daniel B. Shin United States	40	6.1k 1.0×	3.0k 0.9×	2.1k 0.8×	750 0.8×	560 0.6×	105	8.7k
E.M.G.J. de Jong Netherlands	46	4.3k 0.7×	3.4k 1.0×	1.2k 0.5×	1.1k 1.1×	684 0.7×	315	7.6k
Bruce Strober United States	53	7.6k 1.3×	5.1k 1.5×	2.0k 0.8×	1.1k 1.1×	1.0k 1.0×	285	11.1k
Neil J. Korman United States	46	5.6k 1.0×	4.0k 1.2×	2.5k 1.0×	940 1.0×	1.2k 1.2×	163	9.8k
Gerald G. Krueger United States	52	7.7k 1.3×	3.6k 1.1×	3.1k 1.3×	616 0.6×	1.9k 1.9×	121	9.9k
Wolf‐Henning Boehncke Germany	55	8.7k 1.5×	4.4k 1.3×	2.7k 1.1×	859 0.9×	1.5k 1.5×	356	13.2k
Melinda Gooderham Canada	46	4.9k 0.8×	5.0k 1.5×	1.7k 0.7×	602 0.6×	575 0.6×	350	8.6k
Craig L. Leonardi United States	45	11.4k 2.0×	6.4k 1.9×	2.6k 1.1×	1.2k 1.2×	1.7k 1.8×	133	14.1k
Alexander Egeberg Denmark	50	3.4k 0.6×	4.6k 1.4×	1.6k 0.7×	792 0.8×	536 0.5×	315	8.1k

Countries citing papers authored by Paolo Gisondi

Since Specialization

Citations

This map shows the geographic impact of Paolo Gisondi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Gisondi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Gisondi more than expected).

Fields of papers citing papers by Paolo Gisondi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Gisondi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Gisondi. The network helps show where Paolo Gisondi may publish in the future.

Co-authorship network of co-authors of Paolo Gisondi

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Gisondi. A scholar is included among the top collaborators of Paolo Gisondi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Gisondi. Paolo Gisondi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gisondi, Paolo, Francesco Bellinato, Carlotta Galeone, et al.. (2025). Risk of developing psoriatic arthritis in patients with psoriasis initiating treatment with different classes of biologics. Annals of the Rheumatic Diseases. 84(3). 435–441. 5 indexed citations

Ammendola, Serena, et al.. (2025). Refractory Disseminated Annular Elastolytic Giant Cell Granuloma Successfully Treated With Upadacitinib: A Case Report. International Journal of Dermatology.

Gisondi, Paolo & Francesco Bellinato. (2025). Management of IL ‐17 inhibitors‐induced paradoxical eczema in patients with plaque psoriasis. Journal of the European Academy of Dermatology and Venereology.

Bellinato, Francesco, Giovanni Adami, Giorgio Cattani, et al.. (2025). Impact of particulate matter exposure on melanoma risk: A multicentre case–control study. Journal of the European Academy of Dermatology and Venereology. 39(11). 1895–1902. 1 indexed citations

Tillett, William, Peter Nash, Laura C. Coates, et al.. (2024). Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies. Therapeutic Advances in Musculoskeletal Disease. 16. 1759720X241288071–1759720X241288071.

Favaro, Rebecca, Giulia Pavia, Luigi Gargiulo, et al.. (2023). The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV-2 infection and vaccination. British Journal of Dermatology. 189(5). 635–637.

Maurelli, Martina, Giampiero Girolomoni, & Paolo Gisondi. (2023). Cost per responder of adalimumab biosimilars versus methotrexate in patients with psoriasis: a real-life experience. Journal of Dermatological Treatment. 34(1). 2218504–2218504. 4 indexed citations

Caminati, Marco, Eugenio De Corso, Giancarlo Ottaviano, et al.. (2023). Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps. Current Allergy and Asthma Reports. 24(1). 11–23. 10 indexed citations

Bellinato, Francesco, Paolo Gisondi, Angelo Valerio Marzano, et al.. (2023). Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study. Vaccines. 11(4). 740–740. 7 indexed citations

10.

Torres, Tiago, Jordi Galván, Lars Iversen, et al.. (2023). Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review. Dermatology and Therapy. 13(10). 2153–2169. 3 indexed citations

11.

Maurelli, Martina, Paolo Gisondi, & Giampiero Girolomoni. (2023). Advanced Glycation End Products and Psoriasis. Vaccines. 11(3). 617–617. 8 indexed citations

12.

Gisondi, Paolo, Francesco Bellinato, Martina Maurelli, et al.. (2022). Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis. SHILAP Revista de lepidopterología. Volume 12. 213–220. 19 indexed citations

13.

Bellinato, Francesco, Martina Maurelli, Chiara Colato, Paolo Gisondi, & Giampiero Girolomoni. (2021). Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature. SHILAP Revista de lepidopterología. 9(6). e04153–e04153. 4 indexed citations

14.

Bellinato, Francesco, et al.. (2021). Predictors of subsequent primary melanoma: a case–control study. Archives of Dermatological Research. 314(9). 881–885. 1 indexed citations

15.

Gisondi, Paolo, et al.. (2021). Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis. Dermatology. 238(2). 276–282. 3 indexed citations

16.

Piaserico, Stefano, Andrea Conti, Francesco Messina, et al.. (2021). Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis. BioDrugs. 35(4). 469–471. 7 indexed citations

17.

Piaserico, Stefano, Stefano Manfredini, Alessandro Borghi, et al.. (2018). How to improve adherence to treatment in patients with mild-to-moderate psoriasis. Giornale Italiano di Dermatologia e Venereologia. 153(5). 692–697. 9 indexed citations

18.

Gisondi, Paolo, et al.. (2010). Usefulness of the Framingham Risk Score in Patients With Chronic Psoriasis. The American Journal of Cardiology. 106(12). 1754–1757. 54 indexed citations

19.

Gisondi, Paolo, Mario Malerba, Giovanna Malara, et al.. (2010). C-Reactive Protein and Markers for Thrombophilia in Patients with Chronic Plaque Psoriasis. International Journal of Immunopathology and Pharmacology. 23(4). 1195–1202. 30 indexed citations

20.

Linder, Dennis, Paolo Gisondi, Enzo Berardesca, et al.. (2009). Perception of Disease and Doctor-Patient Relationship Experienced by Patients with Psoriasis. American Journal of Clinical Dermatology. 10(5). 325–330. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact